STAAR Surgical Company
STAA · NASDAQ
11/5/2025 | 9/26/2025 | 6/27/2025 | 3/28/2025 | |
|---|---|---|---|---|
| Revenue | – | $94,732 | $44,320 | $42,589 |
| % Growth | – | 113.7% | 4.1% | – |
| Cost of Goods Sold | – | $16,857 | $11,521 | $14,584 |
| Gross Profit | – | $77,875 | $32,799 | $28,005 |
| % Margin | – | 82.2% | 74% | 65.8% |
| R&D Expenses | – | $9,209 | $10,263 | $13,663 |
| G&A Expenses | – | $20,763 | $20,969 | $24,458 |
| SG&A Expenses | – | $44,224 | $47,252 | $49,079 |
| Sales & Mktg Exp. | – | $23,461 | $26,283 | $24,621 |
| Other Operating Expenses | – | $5,952 | $5,248 | $22,664 |
| Operating Expenses | – | $59,385 | $62,763 | $85,406 |
| Operating Income | – | $18,490 | -$29,964 | -$57,401 |
| % Margin | – | 19.5% | -67.6% | -134.8% |
| Other Income/Exp. Net | – | $300 | $4,049 | $2,915 |
| Pre-Tax Income | – | $18,790 | -$25,915 | -$54,486 |
| Tax Expense | – | $9,906 | -$9,103 | -$275 |
| Net Income | – | $8,884 | -$16,812 | -$54,211 |
| % Margin | – | 9.4% | -37.9% | -127.3% |
| EPS | – | 0.18 | -0.34 | -1.1 |
| % Growth | – | 152.9% | 69.1% | – |
| EPS Diluted | – | 0.18 | -0.34 | -1.1 |
| Weighted Avg Shares Out | – | 49,520 | 49,520 | 49,344 |
| Weighted Avg Shares Out Dil | – | 49,520 | 49,520 | 49,344 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $790 | $1,366 | $1,366 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | – | $2,000 | $1,975 | $2,337 |
| EBITDA | – | $26,442 | -$22,741 | -$32,400 |
| % Margin | – | 27.9% | -51.3% | -76.1% |